Viewing Study NCT02172768


Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-02-23 @ 11:35 AM
Study NCT ID: NCT02172768
Status: COMPLETED
Last Update Posted: 2020-12-08
First Post: 2014-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease
Sponsor: Radboud University Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Graft Versus Host Disease Grade II-IV View
None Allogeneic Stem Cell Transplant View
None Acute Myeloid Leucaemia View
None Myelo Dysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pharmacokinetics View
None alternate dosing View
None micafungin View